Search

everythinglearnresearchcommunity

for

Search:↓

Perming and bleaching damage hair differently, with bleached hair having more cysteic acid in the cuticle.

Kaposi's sarcoma lesions might originate from benign tissue changes.

An elderly Chinese man lost all his hair after taking a new heart medication.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

A rare ITGB6 gene variant causes intellectual disability, hair loss, and dental issues.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Washing permed hair after using thioglycolic acid helps reform strong bonds, making hair stronger.

A KRT71 mutation in Hereford cattle in Uruguay causes thin, curly hair and scaly skin.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Arg1+ macrophages may play a role in causing alopecia areata.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Mutations in the DSG4 gene cause specific hair and scalp issues.

Careful light microscopy is crucial for detecting mild cases of pili annulati, which weakens hair and varies widely in expression.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

A specific gene change in APCDD1 increases the risk of hair loss.

TG5 helps maintain hair follicle health, while TG3 aids in hair shaft development.